INTERNATIONAL BIOTECHNOLOGY TRUST PLC
Portfolio Update as at 31 December 2013
Total net assets |
£183.0m |
NAV per share |
331.5p |
Share price |
299.0p |
Total value of unquoted investments |
£25.1m |
Total number of portfolio companies |
85 |
Top Ten Holdings
Company Name |
% NAV |
Celgene |
7.8 |
Gilead |
7.5 |
Biogen |
6.5 |
Amgen |
6.3 |
Regeneron |
5.7 |
Alexion |
4.2 |
Incyte |
3.9 |
Mylan |
3.2 |
Illumina |
3.1 |
Aptiv |
2.9 |
|
----------- |
Total |
51.1 |
Trust Characteristics |
% NAV |
Profitable |
59 |
Turning Profitable 2014 |
9 |
Unprofitable |
32 |
|
----------- |
Total |
100 |
Geographical Allocation |
% NAV |
United States & Canada |
91 |
Europe |
9 |
|
----------- |
Total |
100 |
Quoted/Unquoted allocation |
% NAV |
Quoted |
86 |
Unquoted |
14 |
|
----------- |
Total |
100 |
BNP Paribas Secretarial Services Limited
Company Secretary
28 JANUARY 2014